Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in INMB — Inmune Bio, Inc.

CIK 1000275 TORONTO, A6
Back to INMB Full portfolio

Position in INMB

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$6,973
+$3,941 QoQ
Shares Held
4,279
+59.4% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 83 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in INMB Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,118,794,122 across 427 Biotechnology names. INMB ranks #310 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 6,182,479 $490,208,754
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 980,259 $486,924,048
3 ALNY
Alnylam Pharmaceuticals, Inc.
 875,859 $263,659,830
4 INCY
Incyte Corp
 1,132,050 $128,329,182
5 REGN
Regeneron Pharmaceuticals, Inc.
 174,515 $108,817,078
6 MRNA
Moderna, Inc.
 944,457 $66,140,319
7 INSM
INSMED Inc
 416,487 $44,405,840
8 HALO
Halozyme Therapeutics, Inc.
 545,761 $42,716,712

All Filings in INMB

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,973 4,279
2026-03-31 $3,032 2,684
2025-12-31 $2,156 1,383
2025-09-30 $4,792 2,316
2025-06-30 $112,685 48,782
2025-03-31 $233,227 29,863
2024-12-31 $96,327 20,627
2024-09-30 $334,642 62,086
2024-06-30 $552,140 62,601
2024-03-31 $972,147 82,736
2023-12-31 $650,725 57,791
2023-09-30 $492,063 72,683
2023-06-30 $638,396 70,308
2023-03-31 $391,081 60,539
2022-12-31 $383,817 60,539
2022-09-30 $375,272 60,528
2022-06-30 $520,384 58,867
2022-03-31 $434,522 51,606
2021-12-31 $449,115 44,031
2021-09-30 $2,454,900 126,411
2021-06-30 $1,167,666 66,458
2021-03-31 $778,709 65,548
2020-12-31 $981,504 56,998
2020-09-30 $1,072 104
2020-06-30 $530 101
2020-03-31 $299 90